Abstract | PURPOSE: METHODS: Fifteen eyes of 15 consecutive patients were identified with stage 3 and 4 idiopathic macular holes, these undergoing triamcinolone acetonide assisted ILM peeling for macular holes. These were matched retrospectively with 15 eyes of 15 patients with stage 3 and 4 idiopathic macular holes of less than six months duration, who underwent macular hole surgery with ILM peel augmented with indocyanine green (ICG). Functional and anatomical outcomes were compared between two groups. RESULTS: There were no significant differences between the two groups with reference to demographic features of age, sex, staging of the macular holes and the proportion subsequently undergoing cataract surgery. The mean follow-up period was 6.4 months in the triamcinolone acetonide group and 7.2 months in the ICG group. The hole closure rate was 100% in both group at primary operation. The mean Snellen line change was +1.24 in the intravitreal triamcinolone group and +1.1 in the ICG group. There was a significant improvement in Snellen and Logmar visual acuity in both groups. These differences in visual outcome between the groups were not statistically significant. CONCLUSIONS:
|
Authors | Murat Karacorlu, Hakan Ozdemir, Serra Arf Karacorlu |
Journal | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
(Graefes Arch Clin Exp Ophthalmol)
Vol. 243
Issue 8
Pg. 754-7
(Aug 2005)
ISSN: 0721-832X [Print] Germany |
PMID | 15744526
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Glucocorticoids
- Triamcinolone Acetonide
- Indocyanine Green
|
Topics |
- Basement Membrane
(pathology, surgery)
- Case-Control Studies
- Female
- Glucocorticoids
- Humans
- Indocyanine Green
- Male
- Middle Aged
- Retina
(pathology, surgery)
- Retinal Perforations
(diagnosis, physiopathology, surgery)
- Treatment Outcome
- Triamcinolone Acetonide
- Visual Acuity
(physiology)
- Vitrectomy
- Vitreous Body
|